These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29204573)

  • 1. Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B.
    Cho DY; Hoffman KJ; Gill GS; Lim DJ; Skinner D; Mackey C; Rowe SM; Woodworth BA
    World J Otorhinolaryngol Head Neck Surg; 2017 Mar; 3(1):2-8. PubMed ID: 29204573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
    Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
    Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties.
    Burgess BL; Cavigiolio G; Fannucchi MV; Illek B; Forte TM; Oda MN
    Int J Pharm; 2010 Oct; 399(1-2):148-55. PubMed ID: 20696226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of nasal irrigation with 200 μg/mL amphotericin B after functional endoscopic sinus surgery: a randomized, placebo-controlled, double-blind study.
    Jiang RS; Twu CW; Liang KL
    Int Forum Allergy Rhinol; 2018 Jan; 8(1):41-48. PubMed ID: 29083530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B formulations: a comparative review of efficacy and toxicity.
    Hamill RJ
    Drugs; 2013 Jun; 73(9):919-34. PubMed ID: 23729001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
    Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
    Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide stabilized amphotericin B nanodisks.
    Tufteland M; Pesavento JB; Bermingham RL; Hoeprich PD; Ryan RO
    Peptides; 2007 Apr; 28(4):741-6. PubMed ID: 17293004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole.
    Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J
    Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic analysis of amphotericin B lipid complex versus liposomal amphotericin B in the treatment of fungal infections.
    Kuti JL; Kotapati S; Williams P; Capitano B; Nightingale CH; Nicolau DP
    Pharmacoeconomics; 2004; 22(5):301-10. PubMed ID: 15061680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R; Valdespina S; Dea MA; Molero G; Ballesteros MP; Bolás F; Torrado JJ
    J Antimicrob Chemother; 2008 May; 61(5):1125-31. PubMed ID: 18285313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms.
    Rajendran R; Mowat E; Jones B; Williams C; Ramage G
    Int J Antimicrob Agents; 2015 Sep; 46(3):342-5. PubMed ID: 25979638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Affecting Enhanced Permeation of Amphotericin B Across Cell Membranes and Safety of Formulation.
    Adhikari K; Buatong W; Thawithong E; Suwandecha T; Srichana T
    AAPS PharmSciTech; 2016 Aug; 17(4):820-8. PubMed ID: 26349688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B-silver hybrid nanoparticles: synthesis, properties and antifungal activity.
    Tutaj K; Szlazak R; Szalapata K; Starzyk J; Luchowski R; Grudzinski W; Osinska-Jaroszuk M; Jarosz-Wilkolazka A; Szuster-Ciesielska A; Gruszecki WI
    Nanomedicine; 2016 May; 12(4):1095-1103. PubMed ID: 26772425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice.
    Nelson KG; Bishop JV; Ryan RO; Titus R
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1238-44. PubMed ID: 16569834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].
    Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the permeability of Amphotericin B trough serum albumin dispersions and lipid nanocarriers for oral delivery.
    Marcelino HR; Solgadi A; Chéron M; do Egito EST; Ponchel G
    Int J Pharm; 2023 Nov; 646():123444. PubMed ID: 37757958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis transmembrane conductance regulator activation by the solvent ethanol: implications for topical drug delivery.
    Cho DY; Skinner D; Zhang S; Fortenberry J; Sorscher EJ; Dean NR; Woodworth BA
    Int Forum Allergy Rhinol; 2016 Feb; 6(2):178-84. PubMed ID: 26869199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel lipid delivery system of amphotericin B: drug profile and relevance to clinical practice.
    Rust DM; Jameson G
    Oncol Nurs Forum; 1998; 25(1):35-48. PubMed ID: 9460772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.